SCB002 / SCBIO - LARVOL DELTA

Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects (clinicaltrials.gov) - P1 | N=74 | Not yet recruiting | Sponsor: SCBIO Inc.

First-in-human • New P1 trial • Genetic Disorders • Idiopathic Pulmonary Fibrosis • Immunology • Obesity • Oncology • Pulmonary Disease • Respiratory Diseases • Solid Tumor